David Charles Baker

Insider Reports History

Entity
Individual
Location
100 N. 18 Th Street, Suite 300, Philadelphia, PA
Signature
/s/ Leanne Kelly, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Charles Baker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GRI BIO, Inc. Director Stock Option (Right to Buy) 34.5K $52.4K $1.52 Aug 10, 2023 Direct

Insider Reports Filed by David Charles Baker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GRI GRI BIO, Inc. Aug 10, 2023 1 $100K 4 Aug 14, 2023 Director
GRI Vallon Pharmaceuticals, Inc. Feb 15, 2022 1 $343K 4 Mar 1, 2022 Chief Executive Officer, Director
GRI Vallon Pharmaceuticals, Inc. May 14, 2021 1 $0 4 May 18, 2021 Chief Executive Officer, Director